EU Adviser Slams Drugmaker Over Pay-for-Delay Deals

LUXEMBOURG (CN) – Paying to delay the production of generic drugs violates European Union competition regulations, an adviser to the EU’s highest court said Wednesday.

Read the article on CNS.